Brookdale Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, NY 10029, USA.
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):706-11. doi: 10.1016/j.ijrobp.2010.06.060. Epub 2010 Oct 6.
To evaluate whether complex radiotherapy (RT) planning was associated with improved outcomes in a cohort of elderly patients with unresected Stage I-II non-small-cell lung cancer (NSCLC).
Using the Surveillance, Epidemiology, and End Results registry linked to Medicare claims, we identified 1998 patients aged >65 years with histologically confirmed, unresected stage I-II NSCLC. Patients were classified into an intermediate or complex RT planning group using Medicare physician codes. To address potential selection bias, we used propensity score modeling. Survival of patients who received intermediate and complex simulation was compared using Cox regression models adjusting for propensity scores and in a stratified and matched analysis according to propensity scores.
Overall, 25% of patients received complex RT planning. Complex RT planning was associated with better overall (hazard ratio 0.84; 95% confidence interval, 0.75-0.95) and lung cancer-specific (hazard ratio 0.81; 95% confidence interval, 0.71-0.93) survival after controlling for propensity scores. Similarly, stratified and matched analyses showed better overall and lung cancer-specific survival of patients treated with complex RT planning.
The use of complex RT planning is associated with improved survival among elderly patients with unresected Stage I-II NSCLC. These findings should be validated in prospective randomized controlled trials.
评估在一组未经手术切除的 I 期- II 期非小细胞肺癌(NSCLC)老年患者中,复杂放疗(RT)计划是否与改善结局相关。
我们使用监测、流行病学和最终结果(SEER)登记处与医疗保险索赔相关联,确定了 1998 名年龄 >65 岁、经组织学证实、未经手术切除的 I 期- II 期 NSCLC 患者。患者根据医疗保险医师代码分为中等或复杂 RT 计划组。为了解决潜在的选择偏差,我们使用倾向评分模型。使用 Cox 回归模型比较接受中等和复杂模拟的患者的生存情况,调整倾向评分,并根据倾向评分进行分层和匹配分析。
总体而言,25%的患者接受了复杂 RT 计划。在控制倾向评分后,复杂 RT 计划与更好的总生存(风险比 0.84;95%置信区间,0.75-0.95)和肺癌特异性生存(风险比 0.81;95%置信区间,0.71-0.93)相关。同样,分层和匹配分析显示,接受复杂 RT 计划治疗的患者具有更好的总生存和肺癌特异性生存。
在未经手术切除的 I 期- II 期 NSCLC 老年患者中,使用复杂 RT 计划与改善生存相关。这些发现应在前瞻性随机对照试验中得到验证。